Back
State Street Financial Sel Sec SPDR ETF Vs. Enliven Therapeutics, Inc. Industry Stock Comparison
Buy
53
XLF
State Street Financial Sel Sec SPDR ETF
XLF
State Street Financial Sel Sec SPDR ETF
State Street Financial Sel Sec SPDR ETF
Last Price:
$51.19
Seasonality Move:
0.96%
Sell
40
ELVN
Enliven Therapeutics, Inc.
ELVN
Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc.
Last Price:
$42.94
Seasonality Move:
9.15%
Buy
53
State Street Financial Sel Sec SPDR ETF (XLF)
is a Buy
Is State Street Financial Sel Sec SPDR ETF a Buy, Sell or Hold?
-
The current State Street Financial Sel Sec SPDR ETF [XLF] share price is $49.88. The Score for XLF is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
XLF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Enliven Therapeutics, Inc. (ELVN)
is a Sell
Is Enliven Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Enliven Therapeutics, Inc. [ELVN] share price is $43.16. The Score for ELVN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ELVN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XLF Stock Price Chart
What is State Street Financial Sel Sec SPDR ETF's stock price today?
-
The State Street Financial Sel Sec SPDR ETF share price today is $49.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLF is experiencing slight buying pressure.
ELVN Stock Price Chart
What is Enliven Therapeutics, Inc.'s stock price today?
-
The Enliven Therapeutics, Inc. share price today is $43.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELVN is experiencing buying pressure, which is a positive indicator for future bullish movement.
XLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 49.81 | Sell |
| Chaikin Money Flow: | 14653867 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.71 - 50.43) | Buy |
| Bollinger Bands (100): | (50.42 - 54.7) | Sell |
ELVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.28 | Buy |
| Relative Strength Index (14 RSI): | 74.46 | Buy |
| Chaikin Money Flow: | 2801753 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.87 - 37.43) | Buy |
| Bollinger Bands (100): | (18.99 - 31.53) | Buy |
XLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.17 | Buy |
| 20-day SMA: | 49.23 | Buy |
| 50-day SMA: | 51.13 | Sell |
| 200-day SMA: | 52.69 | Sell |
| 8-day EMA: | 49.44 | Buy |
| 20-day EMA: | 49.61 | Buy |
| 50-day EMA: | 50.79 | Sell |
| 200-day EMA: | 51.75 | Sell |
ELVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.08 | Buy |
| 20-day SMA: | 33.46 | Buy |
| 50-day SMA: | 30.05 | Buy |
| 200-day SMA: | 22.8 | Buy |
| 8-day EMA: | 38.55 | Buy |
| 20-day EMA: | 34.96 | Buy |
| 50-day EMA: | 30.68 | Buy |
| 200-day EMA: | 24.47 | Buy |
State Street Financial Sel Sec SPDR ETF Earnings Growth & XLF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Enliven Therapeutics, Inc. Earnings Growth & ELVN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.60 per share.
State Street Financial Sel Sec SPDR ETF Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | Apr 6 | Apr 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Enliven Therapeutics, Inc. Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | Apr 6 | Apr 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||